We hear the term of "undetectable" with a psa of < .1 used so often.
When I was first diagnosed and had an RALP I bought into the use of this theory. As the months clicked by and I was "undetectable" I was slowly gaining confidence and reassurance that this was true.
Eight months later a .1 shattered my confidence and trust with using this theory. Obviously I didn't understand that it's just clinically accepted reference point. It has nothing to do with your whole disease state. Within nine weeks I was at .4 and the EBRT and adt treatment unfolded.
After this experience I became a huge believer in the benefit of usPSA testing. While most docs won't treat until a .1, knowing early gives the patient time to research the next best treatment.
While the psa threshold is a decent biomarker after treatment it should be followed up with imaging and blood/liquid biopsies.
Here's what a research doc at UC Davis shared with me:
We are indeed using serial liquid biopsies at UC Davis to monitor the growth/progression of prostate cancer over time. We frequently see the circulating tumor DNA rise before the PSA increases, sometimes by several months.
Sometimes, prostate cancer changes and stops producing PSA completely. Then, serum PSA is no longer a good marker of cancer growth, but the serial liquid biopsy remains a good marker.
Whether screening or following treatment progress it's evident that multiple tools help get ahead of the disease the best we can.